569
vs
F
FTSE Straits Times Singapore
569
Over the past 12 months, Vicplas International Ltd has outperformed FTSE Straits Times Singapore, delivering a return of +3% compared to the FTSE Straits Times Singapore's 0% growth.
Stocks Performance
569 vs FTSE Straits Times Singapore
Performance Gap
569 vs FTSE Straits Times Singapore
Performance By Year
569 vs FTSE Straits Times Singapore
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Vicplas International Ltd
Glance View
VicPlas International Ltd. operates as an investment holding company, which engages in the research, design, development, and manufacture of medical devices and plastic building products. The firm designs, develops and manufactures sterile and non-sterile medical devices through its subsidiaries, Forefront Medical Technology (Pte) Ltd, Forefront Medical Investment Pte. Ltd. and XentiQ (Pte.) Ltd. in Singapore; Forefront (Xiamen) Medical Devices Co., Ltd and Forefront Medical Technology (Jiangsu) Co., Ltd in China; and Arrow Medical Limited in the United Kingdom. The firm manufactures and distributes piping systems for diverse industries, including waste and potable water systems for residential homes, schools, commercial and industrial buildings; underground electrical and internal building wire piping systems; and data and signal line piping systems by telecommunications companies, through its subsidiaries, Vicplas Holdings Pte Ltd in Singapore and Rimplas Industries Sdn. Bhd. in Malaysia.
